Whooping cough is a highly contagious respiratory disease spread by the bacteria Bordetella pertussis (pertussis ... Parents ...

As whooping cough cases rise in the U.S., a new nasal vaccine developed ... caused by the Bordetella pertussis bacteria. However, the vaccines fail to clear bacteria from the upper respiratory ...

As whooping cough cases rise in the U.S., a new nasal vaccine developed by Tulane University ... effective at preventing whooping cough, caused by the Bordetella pertussis bacteria. However, the ...

However, to help reduce the spread, researchers at Tulane University of Medicine in New Orleans developed a new nasal vaccine for the ... caused by the bacterium Bordetella pertussis.

Whooping cough, due to Bordetella pertussis and ... severe reactogenicity profile Live-attenuated vaccines Potential protection after a single intranasal administration; Potential impact on ...

Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored ...

the leading next generation intranasal pertussis vaccine. This innovative medicine designation has been awarded to BPZE1 indicated for active immunization against both upper respiratory tract B.